[HTML] sciencedirect.com

[HTML][HTML] Pediatric Acute Myeloid Leukemia with t (8; 16)(p11; p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin …

EA Coenen, CM Zwaan, CJ Harrison, OA Haas… - Blood, 2012 - Elsevier
Abstract Abstract 2516 Introduction: In pediatric acute myeloid leukemia (AML) cytogenetic
abnormalities are important for prognosis and treatment stratification. Some recurring …
相关文章

Pediatric Acute Myeloid Leukemia with t (8; 16)(p11; p13): A Distinct Clinical and Biological Entity.: Results of a Collaborative Stydy by the International Berlin …

EA Coenen, CM Zwaan, CJ Harrison, OA Haas… - 2012 - pure.au.dk
Pediatric Acute Myeloid Leukemia with t(8;16)(p11;p13): A Distinct Clinical and Biological Entity.
Results of a Collaborative Stydy by the International Berlin-Frankfurt-Münster AML Study Group …

Pediatric Acute Myeloid Leukemia with t (8; 16)(p11; p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin-Frankfurt …

EA Coenen, CM Zwaan, CJ Harrison, OA Haas… - 2012 - ashpublications.org
Abstract Abstract 2516 Introduction: In pediatric acute myeloid leukemia (AML) cytogenetic
abnormalities are important for prognosis and treatment stratification. Some recurring …